Taksa Lifescience Private Limited
About Taksa Lifescience Private Limited
Data last updated:
Taksa Lifescience Private Limited is a private limited company based in Chandigarh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 09 May 2023.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U21001CH2023PTC045057.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹65 Lakh. It is led by directors Ravinder Kumar Sharma and Gaurav Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 108, Sector 21 – A, Chandigarh, India – 160022.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.32 Cr. For the same year it recorded a net profit of ₹7.85 Lakh (net margin 0.6%) and EBITDA of ₹61.37 Lakh (EBITDA margin 4.6%).
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹3.92 Cr on record. Court records list 13 cases involving the company, including 13 filed against it; 11 cases are pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No – 108, Sector 21 – A, Chandigarh, India – 160022
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Taksa Lifescience Private Limited
The main business activity of Taksa Lifescience is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Taksa Lifescience Private Limited FY 2025 filings available
Taksa Lifescience Private Limited reported revenue of ₹13.32 Cr for FY 2025.
Financial Statement Summary of Taksa Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹61.37 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹7.85 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Taksa Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.6% | •••• |
| Net Profit Margin | 0.6% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Taksa Lifescience are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Taksa Lifescience Private Limited
Taksa Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravinder Kumar Sharma | Director | 09 May 2023 | 3 Years 5 Months | Current |
| Gaurav Sharma | Director | 09 May 2023 | 3 Years 5 Months | Current |
Peer Comparison of Taksa Lifescience Private Limited
Taksa Lifescience Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indulge Ventures Private Limited | ₹13.36 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Nagpur, Maharashtra, India |
| Converge Electronics Trading (India) Private Limited | ₹13.36 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Bangalore, Karnataka, India |
| SCL Commercial India Private Limited | ₹13.35 Cr (FY 2024) | •••• | •••• | 474.0% | •••• | New Delhi, Delhi, India |
| Real Line Partition Private Limited | ₹13.34 Cr (FY 2025) | •••• | •••• | 245.0% | •••• | Mumbai, Maharashtra, India |
| Starteck Int Appliance Private Limited | ₹13.34 Cr (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Taksa Lifescience Private Limited this company | ₹13.32 Cr (FY 2025) | •••• | •••• | •••• | Chandigarh, India | |
| Lovkik Traders Private Limited | ₹13.31 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Pune, Maharashtra, India |
| Nestlabs Automation Private Limited | ₹13.3 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Noida, Uttar Pradesh, India |
| Pick Ur Needs E-Commerce Private Limited | ₹13.28 Cr (FY 2025) | •••• | •••• | 158.0% | •••• | Delhi, India |
| Sidhsai Healthcare Private Limited | ₹13.26 Cr (FY 2025) | •••• | •••• | 111.0% | •••• | Belgaum, Karnataka, India |
| Global Parasol Re-Insurance Brokers Private Limited | ₹13.23 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Taksa Lifescience by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Taksa Lifescience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2024 | Canara Bank | ₹1 Cr | Open |
| 11 Aug 2024 | Hdfc Bank Limited | ₹3.92 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Taksa Lifescience Private Limited
Taksa Lifescience Private Limited has 13 court cases on record: 13 filed against it. 11 cases are pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 11 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Sterkem Pharma Private Limited | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by Samchem India Private Limited | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Zoic Biotech Private Limited | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Century Pharmaceuticals Limited | Pending |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Century Pharmaceuticals Limited | Disposed |
Full case history
All 13 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Taksa Lifescience Private Limited
Employment history and EPFO contributions of people linked to Taksa Lifescience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Taksa Lifescience Private Limited
Taksa Lifescience Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Ayush Sharma ceased to be Director on 01 Apr 2025.
Credit Ratings, Litigation & Regulatory Alerts for Taksa Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Taksa Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Taksa Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Taksa Lifescience Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Taksa Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taksa Lifescience Private Limited
Taksa Lifescience is an active private limited company based in Chandigarh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 09 May 2023 (3+ years old) and is registered under CIN U21001CH2023PTC045057.
Taksa Lifescience reported revenue of ₹13.32 Cr for FY 2025.
Taksa Lifescience has 2 current directors:
- Ravinder Kumar Sharma - Director
- Gaurav Sharma - Director
Taksa Lifescience reported a net profit of ₹7.85 Lakh (net margin 0.6%) and EBITDA of ₹61.37 Lakh (EBITDA margin 4.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Taksa Lifescience is U21001CH2023PTC045057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taksa Lifescience has 13 court cases on record: 13 filed against it. 11 are pending.
Taksa Lifescience was incorporated on 09 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Taksa Lifescience by revenue are Indulge Ventures Private Limited, Converge Electronics Trading (India) Private Limited, SCL Commercial India Private Limited, Real Line Partition Private Limited, Starteck Int Appliance Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Ayush Sharma ceased to be Director on 01 Apr 2025. Ayush Sharma was appointed as Director on 09 May 2023. Gaurav Sharma was appointed as Director on 09 May 2023. Taksa Lifescience has 4 board changes on record in total.
The registered office of Taksa Lifescience is at House No – 108, Sector 21 – A, Chandigarh, India – 160022.
Taksa Lifescience has an authorised share capital of ₹1 Cr and a paid-up capital of ₹65 Lakh.